open access

Vol 65, No 5 (2015)
Invited editorial
Published online: 2015-11-18
Get Citation

120 years — from Roentgen’s discovery to stereotactic radiosurgery

Bogusław Maciejewski
DOI: 10.5603/NJO.2015.0074
·
Nowotwory. Journal of Oncology 2015;65(5):373-382.

open access

Vol 65, No 5 (2015)
Invited editorial
Published online: 2015-11-18

Abstract

This paper presents some details concerning the first few years after discovery of X-rays by Roentgen. Progress in radiotherapy during 120 years is discussed and illustrated by diagrams of milestones in the physics, technology and methods of radiation therapy. Discussion is focused on two topics: “physics versus biology” and “empirical radiotherapy versus clinical trials”. Evolution of radiotherapy has been based on the so-called “Paterson school” for the first 50 years which moved since 1968 into the “Fletcher school”. Rationale of this school was based on experimental and clinical radiobiology studies carried out in the 1950s–1970s, recognised almost all mechanisms of tumour and normal tissue response to radiation. For over 80 years, retrospective clinical studies and empirical experience have built up the fundamentals of modern radiotherapy and have served to design clinical trials. However, many “evidence based trials” provide some uncertainties and offer only average results as guidelines to treat individual patients. Trials are critically discussed based on the results of the selected studies with suggestions for careful interpretation based on logic and practical common sense. Studies of molecular biology and genetics clearly show that each tumour has own individual “fingerprint”, which moves all oncology including radiotherapy to individual personalised therapy. This is an important challenge for near future.

Abstract

This paper presents some details concerning the first few years after discovery of X-rays by Roentgen. Progress in radiotherapy during 120 years is discussed and illustrated by diagrams of milestones in the physics, technology and methods of radiation therapy. Discussion is focused on two topics: “physics versus biology” and “empirical radiotherapy versus clinical trials”. Evolution of radiotherapy has been based on the so-called “Paterson school” for the first 50 years which moved since 1968 into the “Fletcher school”. Rationale of this school was based on experimental and clinical radiobiology studies carried out in the 1950s–1970s, recognised almost all mechanisms of tumour and normal tissue response to radiation. For over 80 years, retrospective clinical studies and empirical experience have built up the fundamentals of modern radiotherapy and have served to design clinical trials. However, many “evidence based trials” provide some uncertainties and offer only average results as guidelines to treat individual patients. Trials are critically discussed based on the results of the selected studies with suggestions for careful interpretation based on logic and practical common sense. Studies of molecular biology and genetics clearly show that each tumour has own individual “fingerprint”, which moves all oncology including radiotherapy to individual personalised therapy. This is an important challenge for near future.

Get Citation
About this article
Title

120 years — from Roentgen’s discovery to stereotactic radiosurgery

Journal

Nowotwory. Journal of Oncology

Issue

Vol 65, No 5 (2015)

Article type

Invited editorial

Pages

373-382

Published online

2015-11-18

Page views

3485

Article views/downloads

5884

DOI

10.5603/NJO.2015.0074

Bibliographic record

Nowotwory. Journal of Oncology 2015;65(5):373-382.

Authors

Bogusław Maciejewski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl